QMEDICS is a young Swiss-based medical device manufacturer founded in 2008. Our long year experience in the medical device industry has made us very flexible and highly capable of finding the optimum solution for every customer specific need. We were until 2016 a pure contracted manufacturing company – since then we became a PLM (private label) manufacturing of our own Peripheral product portfolio.

This was a company strategy change that resulted in a new management, new and more R&D engineers, the start of direct customer contact, a sales and marketing strategy in short, a start up in an experienced environment this combination is just ideal.

Qmedics is a trusted partner with in-house stent and balloon development, manufacturing and logistical service. We supply custom tailored products, solutions and technologies. We produce already for big players in PTA and PTCA medical world.

Our Expertise are the following technologies:

Our investors made it possible to expand our product portfolio with “Easyx“ a liquid Embolic that provides another treatment option for peripheral physicians - the start in Qmedics embolization portfolio, Qmedics embolization pipeline: occlusion balloon and an embolization plug

The EASYX™ Liquid Embolic is a new injectable, precipitating polymeric agent for the obliteration of vascular spaces through direct puncture or catheter access performed under X-ray guidance. The embolic liquid is iodinized Polyvinyl Alcohol (PVA) Polymer ether. Iodine groups are covalently grafted to the PVA polymer backbone, whereby a stable nondegradable polymer with the desired features is created. The resulting polymer is dissolved in Dimethyl Sulfoxide (DMSO).

EASYX™ is CE-marked since December 2016 for the use in peripheral vasculature. The safety and efficacy of EASYX™ embolization liquid for the percutaneous treatment of vascular lesions, i.e. embolization of varicocele, type II endoleaks, portal vein before surgery, active peripheral bleeding or angiomyolipoma (AML) was proven in a clinical trial EASYX-1.

EASYX-1: A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications. Publication is planned very soon.